troglitazone has been researched along with serine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pestell, RG; Pradeep, A; Rana, B; Sharma, C | 1 |
| Farmer, SR; Liu, J | 1 |
| Dansette, PM; Jaouen, M; Johnson, EF; Macherey, AC; Mansuy, D; Marques-Soares, C; Melet, A; Sari, MA; Schoch, GA | 1 |
3 other study(ies) available for troglitazone and serine
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor gamma activation modulates cyclin D1 transcription via beta-catenin-independent and cAMP-response element-binding protein-dependent pathways in mouse hepatocytes.
Topics: Animals; beta Catenin; Blotting, Western; Cell Division; Cell Line; Chromans; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclin D1; Cytoskeletal Proteins; Enzyme Activation; Enzyme Inhibitors; Genes, Reporter; Hepatocytes; Humans; Hypoglycemic Agents; Ligands; Liver; Luciferases; Mice; Mutation; Okadaic Acid; Plasmids; Receptors, Cytoplasmic and Nuclear; Serine; Thiazolidinediones; Trans-Activators; Transcription Factors; Transcription, Genetic; Transfection; Troglitazone | 2004 |
Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic
Topics: Adipocytes; Alanine; Animals; Azo Compounds; beta Catenin; Blotting, Western; CCAAT-Enhancer-Binding Protein-alpha; Cell Differentiation; Cell Line; Chromans; Coloring Agents; Cytoskeletal Proteins; Fibroblasts; Genes, Reporter; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Lipids; Luciferases; Mice; Mutation; Phosphorylation; Plasmids; PPAR gamma; Response Elements; RNA; Serine; Signal Transduction; Thiazolidinediones; Trans-Activators; Transcriptional Activation; Troglitazone | 2004 |
Analysis of human cytochrome P450 2C8 substrate specificity using a substrate pharmacophore and site-directed mutants.
Topics: Amiodarone; Animals; Arginine; Aryl Hydrocarbon Hydroxylases; Asparagine; Catalysis; Chromans; Computer Simulation; Cytochrome P-450 CYP2C8; Diclofenac; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Indoles; Isoleucine; Models, Molecular; Mutagenesis, Site-Directed; Paclitaxel; Phenylalanine; Rabbits; Serine; Substrate Specificity; Sulfonamides; Thiazolidinediones; Tretinoin; Troglitazone | 2004 |